Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Camurus

Market Cap: SEK 29.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 16.8b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Xbrane Biopharma

Market Cap: SEK 330.0m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Diamyd Medical

Market Cap: SEK 917.3m

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Guard Therapeutics International

Market Cap: SEK 357.0m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Ascelia Pharma

Market Cap: SEK 498.3m

A biotech company, focuses on orphan oncology treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 14.1m

Develops drugs for lipid related diseases in Sweden.

Corline Biomedical

Market Cap: SEK 240.0m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 62.2m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, as well as opioid overdose and anaphylactic shock.

Devyser Diagnostics

Market Cap: SEK 1.7b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Active Biotech

Market Cap: SEK 340.8m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Egetis Therapeutics

Market Cap: SEK 1.1b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

SynAct Pharma

Market Cap: SEK 743.0m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

BioInvent International

Market Cap: SEK 2.4b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Mendus

Market Cap: SEK 262.0m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Hansa Biopharma

Market Cap: SEK 1.6b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

AlzeCure Pharma

Market Cap: SEK 258.7m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Moberg Pharma

Market Cap: SEK 435.6m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Initiator Pharma

Market Cap: SEK 212.8m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

AddLife

Market Cap: SEK 22.3b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Genovis AB (publ.)

Market Cap: SEK 1.8b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Magle Chemoswed Holding

Market Cap: SEK 590.9m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

Biotage

Market Cap: SEK 11.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Swedencare

Market Cap: SEK 6.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Elicera Therapeutics

Market Cap: SEK 312.1m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

FluoGuide

Market Cap: SEK 570.7m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Vitrolife

Market Cap: SEK 20.8b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

BioGaia

Market Cap: SEK 10.6b

A healthcare company, provides probiotic products worldwide.

Swedish Orphan Biovitrum

Market Cap: SEK 100.8b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.